| 1 |
MYL-1701P
|
|
510 KB |
| 2 |
Marzeptacog alfae
|
|
498 KB |
| 3 |
Durvalumab1
|
|
490 KB |
| 4 |
Novel CoronaVirus2019-nCoV Vaccine
|
|
306 KB |
| 5 |
Oral Eflornithine NSRT2020
|
|
2898 KB |
| 6 |
Carvedilol _ Ivabradine Hydrochloride eq. to Ivabradine film coated tablets (Phase IV)
|
|
316 KB |
| 7 |
Efgartigimod PH20 SC
|
|
494 KB |
| 8 |
Selexipag
|
|
492 KB |
| 9 |
Taliglucerase Alfa
|
|
492 KB |
| 10 |
Bevacizumab
|
|
316 KB |
| 11 |
JS016
|
|
318 KB |
| 12 |
AMT-101
|
|
503 KB |
| 13 |
Bilastine + Montelukast sodium IP eq. to Montelukast Oral Suspension (Phase III
|
|
318 KB |
| 14 |
Levobupivacaine Hydrochloride eq. to Levobupivacaine + Dextrose liquid injection (Phase III)
|
|
321 KB |
| 15 |
Bepotastine Besilate + Montelukast Sodium IP eq. to Montelukast film coated tablets (Phase III)
|
|
285 KB |
| 16 |
Pregabalin (as sustained release) IP + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptyline IP tablets (Phase III)
|
|
300 KB |
| 17 |
Mirabegron (ER) + Solifenacin Succinate IP tablets (Phase III
|
|
297 KB |
| 18 |
Budesonide + Glycopyrronium + Formoterol Fumarate inhalation Powder (Phase IV)
|
|
304 KB |
| 19 |
noxaparin) in COVID-19
|
|
501 KB |
| 20 |
Metformin HCl (SR) + Myo-Inositol film coated bilayered tablets (Phase III)
|
|
330 KB |
| 21 |
RIVACA
|
|
3602 KB |
| 22 |
Potassium Chloride (K-Lyte)
|
|
419 KB |
| 23 |
Baricitinib
|
|
500 KB |
| 24 |
Alogliptin Benzoate eq. to Alogliptin + Metformin Hydrochloride IP Film Coated Tablet (Phase IV)
|
|
281 KB |
| 25 |
Randomized
|
|
2969 KB |
| 26 |
Brimonidine IP + Brinzolamide IP + Timolol eq. to Timolol Maleate IP + Benzalkonium chloride solution IP (as preservative) + Water for injection IP q.s. per ml Ophthalmic Suspension (Phase III)
|
|
322 KB |
| 27 |
Marzeptacog Alfa
|
|
185 KB |
| 28 |
Lidocaine Hydrochloride IP + Diltiazem Hydrochloride IP Gel (Phase III)
|
|
286 KB |
| 29 |
AS012
|
|
506 KB |
| 30 |
Daclatasvir dihydrochloride IP eq. to Daclatasvir + Sofosbuvir film coated tablet with or without Nitazoxanide in combination with standard of care in adult patients with moderate Covid-19 (Phase IIB)
|
|
3097 KB |
| 31 |
Pregabalin IP (as prolonged release form) + Mecobalamin IP + Nortriptyline HCl film coated bilayered tablet (Phase III)
|
|
3209 KB |
| 32 |
Pioglitazone IP + Vildagliptin (as sustained release form) Film coated bilayered tablet (Phase III)
|
|
3024 KB |
| 33 |
Amino Acid + Glucose 7.5% with Electrolytes and Vitamin B1 Injection (BFLUID) (1000 ml Bag each) (Phase III)
|
|
4216 KB |
| 34 |
Chikungunya vaccine (Inactivated)
|
|
533 KB |
| 35 |
inebilizumab
|
|
506 KB |
| 36 |
LY3471851
|
|
503 KB |
| 37 |
Mycobacterium w (Heat KilledInjection
|
|
394 KB |
| 38 |
SARS-CoV-2 (Covid-19) Vaccine
|
|
1184 KB |
| 39 |
Saxagliptin + Dapagliflozin Film coated tablets (Phase IV)
|
|
2849 KB |
| 40 |
Ketorolac Tromethamine 30mg
|
|
3039 KB |
| 41 |
Whole Virion, Inactivated Corona Virus Vaccine,BBV152
|
|
1793 KB |
| 42 |
Durvalumab
|
|
1426 KB |
| 43 |
Gam COVID Vac Combined vector vaccine component one and component two
|
|
1928 KB |
| 44 |
Chlorthalidone IP + Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium film coated tablets (Phase III)
|
|
2804 KB |
| 45 |
Insulin Glargine
|
|
518 KB |
| 46 |
Intramuscular Injection of Paracetamol 500 mg/2ml
|
|
2812 KB |
| 47 |
SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment)
|
|
561 KB |
| 48 |
Bemcentinib
|
|
440 KB |
| 49 |
Betamethasone Dipropionate USP + Clotrimazole USP + Gentamicin Sulfate USP Cream (Phase III)
|
|
2397 KB |
| 50 |
oral Etrasimod
|
|
2964 KB |
| 51 |
M/s Synokem Pharmaceuticals Ltd
|
|
1087 KB |
| 52 |
LIB003 with Evolocumab
|
|
302 KB |
| 53 |
Pantoprazole Sodium IP Aspirin IP Capsules
|
|
664 KB |
| 54 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrochloride Hydrate IP eq. to Teneligliptin tablets (Phase III)
|
|
2943 KB |
| 55 |
Acotiamide Hydrochloride hydrate SR Tablet 300mg
|
|
3185 KB |
| 56 |
Follicle-Stimulating Hormone and Human Chorionic Gonadotropin
|
|
1997 KB |
| 57 |
Iguratimod tablets 25 mg
|
|
12792 KB |
| 58 |
Abemaciclib
|
|
1306 KB |
| 59 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
2608 KB |
| 60 |
Osimertinib Vs Savolitinib
|
|
494 KB |
| 61 |
Amivantamab & Carboplatin
|
|
494 KB |
| 62 |
SAR442168(Multiple Sclerosis)
|
|
498 KB |
| 63 |
Lasmiditan
|
|
502 KB |
| 64 |
lasmiditan (Migraine)
|
|
502 KB |
| 65 |
oral Etrasimod
|
|
392 KB |
| 66 |
Ticagrelor SR Tablets 120mg/180mg
|
|
3334 KB |
| 67 |
Lumasiran
|
|
1801 KB |
| 68 |
Desidustat
|
|
285 KB |
| 69 |
Metformin Hydrochloride + Doxycycline Hyclate gel (Phase II)
|
|
3020 KB |
| 70 |
Reversible Inhibition of Sperm under Guidance (RISUG)
|
|
227 KB |
| 71 |
Ruxolitinib
|
|
1483 KB |
| 72 |
PNB-001
|
|
10107 KB |
| 73 |
Gepotidacinrevised
|
|
502 KB |
| 74 |
Osimertinib Versus lazertinib
|
|
1456 KB |
| 75 |
Bosutinib tab
|
|
292 KB |
| 76 |
HRF-10071 tab
|
|
226 KB |
| 77 |
Semaglutide (T2diabetes)
|
|
508 KB |
| 78 |
GSK3196165
|
|
535 KB |
| 79 |
Teriflunomide
|
|
414 KB |
| 80 |
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin + Pioglitazone Hydrochloride eq. to Pioglitazone film coated tablets (Phase III)
|
|
3333 KB |
| 81 |
SAR442168 to Placebo
|
|
500 KB |
| 82 |
Epinephrine Sublingual tab
|
|
202 KB |
| 83 |
2'0 Methyl Antisense Oligonucleotide
|
|
290 KB |
| 84 |
Capmatinib
|
|
261 KB |
| 85 |
Evenamide
|
|
272 KB |
| 86 |
Ligelizumab
|
|
509 KB |
| 87 |
nWhole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152D)
|
|
264 KB |
| 88 |
Alpelisib
|
|
264 KB |
| 89 |
SAR442168
|
|
481 KB |
| 90 |
dimethyl Fumarate
|
|
500 KB |
| 91 |
PF-06826647n
|
|
509 KB |
| 92 |
Thymosin a-1 for Injection 1.6mg
|
|
2970 KB |
| 93 |
Evobrutinib
|
|
403 KB |
| 94 |
oral Semaglutide
|
|
505 KB |
| 95 |
Bilastine Tablet 40 mg
|
|
4257 KB |
| 96 |
Bilastine tablet 40mg
|
|
4275 KB |
| 97 |
Fluticasone Furoate + Oxymetazoline hydrochloride IP nasal spray (Phase III)
|
|
3016 KB |
| 98 |
Adjuvant Durvalumab
|
|
378 KB |
| 99 |
C21n
|
|
613 KB |
| 100 |
Typhoid Vi Conjugate Vaccine I.P.n
|
|
295 KB |
| 101 |
Niclosamide IM depot Injection
|
|
2410 KB |
| 102 |
Azelnidipine 8 mg plus Metoprolol Succinate ER 50 mg tab and Azelnidipine 16 mg plus Metoprolol Succinate ER 50 mg tab
|
|
13899 KB |
| 103 |
Gemcitabine revised
|
|
775 KB |
| 104 |
DFV890
|
|
487 KB |
| 105 |
Otilimab
|
|
325 KB |
| 106 |
Dapagliflozin
|
|
372 KB |
| 107 |
Azelnidipine IP + Olmesartan Medomoxil IP film coated tablet (Phase III)
|
|
2918 KB |
| 108 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as gastro resistant pellets) hard gelatin capsules (Phase III)
|
|
3280 KB |
| 109 |
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
|
|
2002 KB |
| 110 |
Trastuzumab Deruxtecan
|
|
491 KB |
| 111 |
Capaivasertib+Abiraterone
|
|
331 KB |
| 112 |
TRC041266
|
|
10239 KB |
| 113 |
PF-06865571
|
|
377 KB |
| 114 |
Bepotastine Besilate + Ketorolac Tromethamine IP + Benzalkonium Chloride IP (as preservative) per ml Ophthalmic Solution (Phase III)
|
|
3761 KB |
| 115 |
Inosine Pranobex 500 mg
|
|
11600 KB |
| 116 |
Mirikizumab
|
|
259 KB |
| 117 |
Desidustat tab
|
|
11490 KB |
| 118 |
PF-06826647
|
|
260 KB |
| 119 |
Secukinumabd
|
|
257 KB |
| 120 |
Netarsudil Ophthalmic sol 0.02%`w/v
|
|
13846 KB |
| 121 |
Erenumab
|
|
497 KB |
| 122 |
Perampanel
|
|
305 KB |
| 123 |
Pregabalin ER
|
|
194 KB |
| 124 |
Trenexamic Acid
|
|
257 KB |
| 125 |
S (-) Metoprolol Succinate IH + Efonidipine Hydrochloride Ethanolate IH modified release uncoated bilayered tablets (Phase III)
|
|
1595 KB |
| 126 |
Typhoid Vi Conjugate Vaccine I.P.1
|
|
566 KB |
| 127 |
Typhoid Vi Conjugate Vaccine I.P.
|
|
566 KB |
| 128 |
Efonidipine Hydrochloride Ethanolate + Chlorthalidone IP uncoated bilayered tablets (Phase III)
|
|
4512 KB |
| 129 |
Lorlatinib tab 25 rmg
|
|
241 KB |
| 130 |
Brolucizumab
|
|
312 KB |
| 131 |
Gepotidacin
|
|
483 KB |
| 132 |
Gemcitabine
|
|
367 KB |
| 133 |
Fitusiran
|
|
475 KB |
| 134 |
ct Umifenovir Hcl cap
|
|
1833 KB |
| 135 |
Dacomitinib tab 15 rm
|
|
234 KB |
| 136 |
Novel Corona Virus 2019-nCoV Vaccine
|
|
1665 KB |
| 137 |
SCD411 And Eylea
|
|
502 KB |
| 138 |
VIB4920
|
|
318 KB |
| 139 |
Somapacitan
|
|
493 KB |
| 140 |
Whole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152)
|
|
330 KB |
| 141 |
Pirfenidone 267 mg tab
|
|
1675 KB |
| 142 |
Dienogest (Ph IV)
|
|
254 KB |
| 143 |
Topiroxostat tablets 20 mg/40mg/60 mg
|
|
248 KB |
| 144 |
Naftifine Hydrochloride Gel 2%
|
|
232 KB |
| 145 |
Hydrocorticosone Acetate
|
|
379 KB |
| 146 |
PF-06480605
|
|
377 KB |
| 147 |
Acodiamide Hydrochloride 300 mg
|
|
1873 KB |
| 148 |
Lipoprotein
|
|
674 KB |
| 149 |
C21
|
|
509 KB |
| 150 |
Acalabrutinib
|
|
399 KB |
| 151 |
Umifenovir
|
|
2588 KB |
| 152 |
Sphaeranthus Indicus Extract
|
|
2203 KB |
| 153 |
Measles and Rubella vaccine (Live)
|
|
288 KB |
| 154 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.
|
|
275 KB |
| 155 |
Benidipine Hydrochloride + Chlorthalidone IP Film coated tablets (Phase III)
|
|
273 KB |
| 156 |
Yellow Fever Vaccine (live) I.P.
|
|
220 KB |
| 157 |
Hepcidin Mimetic PTG-300
|
|
496 KB |
| 158 |
BDB001
|
|
236 KB |
| 159 |
Colloidal silver BP 50 ppm
|
|
12437 KB |
| 160 |
IIIM-290
|
|
942 KB |
| 161 |
Azacitidine
|
|
250 KB |
| 162 |
Ulinastatin for Injection
|
|
1431 KB |
| 163 |
Favipiravir & Umifenovir
|
|
12027 KB |
| 164 |
Nafamostat Mesilate for inj
|
|
11361 KB |
| 165 |
ZYBK2
|
|
9991 KB |
| 166 |
2-Deoxy-D-Glucose (2-DG)
|
|
240 KB |
| 167 |
NitazoxanideTablet 500 mgHydroxychloroquine Tablet 200 mg
|
|
1361 KB |
| 168 |
Cocculus hirsutus
|
|
1154 KB |
| 169 |
Favipiravir
|
|
12309 KB |
| 170 |
NitazoxanideTabet 500 mg and Hydroxychloroquine Tablet 200 mg
|
|
1456 KB |
| 171 |
Dutasteride topical
|
|
371 KB |
| 172 |
Dustasteride Topical solution 0.01% w/v, 0.02% w/v and 0.005% w/v
|
|
679 KB |
| 173 |
BCG vaccine
|
|
219 KB |
| 174 |
Sotagliflozin
|
|
534 KB |
| 175 |
PIK3CA
|
|
296 KB |
| 176 |
Favipiravir
|
|
2366 KB |
| 177 |
Mycobacterium w (Heat Killed) Injection1
|
|
235 KB |
| 178 |
Mycobacterium w (Heat Killed) Injection2
|
|
235 KB |
| 179 |
Remdesevir (GS-5734) for inj 100 mg
|
|
1914 KB |
| 180 |
Mycobacterium w (Heat Killed) Injection
|
|
209 KB |
| 181 |
VPM1002(recombinant BCG) vaccine
|
|
207 KB |
| 182 |
Osimertinib
|
|
399 KB |
| 183 |
S.C. Secukinumab
|
|
360 KB |
| 184 |
VIS649
|
|
375 KB |
| 185 |
CPI-613
|
|
498 KB |
| 186 |
lumasiran
|
|
493 KB |
| 187 |
Concizumab
|
|
497 KB |
| 188 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium +Cilnidipine IP Film coated tablets (Phase III)
|
|
309 KB |
| 189 |
CA-170
|
|
234 KB |
| 190 |
Zika Virus Vaccine (Adsorbed), Zika Virus Vaccine (Adsorbed)
|
|
221 KB |
| 191 |
vaporized cannabinoids
|
|
225 KB |
| 192 |
5-aminolevulinic Acid
|
|
384 KB |
| 193 |
Bilastine + Montelukast Sodium IP eq. to Montelukast Film coated tablets
|
|
288 KB |
| 194 |
Oral Pharmacokinetics and Safety of TRC041266 Powder with TRC4186 Tablet
|
|
195 KB |
| 195 |
Intravenous Secukinimab
|
|
497 KB |
| 196 |
Secukinumab
|
|
497 KB |
| 197 |
Tirzepatide
|
|
518 KB |
| 198 |
DE-109
|
|
258 KB |
| 199 |
Glycopyrrolate IP eq. to Glycopyrronium + Arformoterol Tartrate eq. to Arformoterol Inhalation solution (Phase III)
|
|
303 KB |
| 200 |
Canagliflozin + Metformin HCl Film coated tablets (Phase IV)
|
|
216 KB |
| 201 |
M/s Biological E Limited
|
|
572 KB |
| 202 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
336 KB |
| 203 |
Inactivated Hepatitis A vaccine
|
|
281 KB |
| 204 |
Selpercatinib
|
|
491 KB |
| 205 |
ZYBK2
|
|
206 KB |
| 206 |
zelnidipine 8 mg plus Telmisartan 40 mg and Azelnidipine 16 mg plus Telmisartan 40mg tab versus Azelnidipine tab 16 mg and Telmisartan tab 40 mg
|
|
376 KB |
| 207 |
Cabozantinib or Vandetanib
|
|
419 KB |
| 208 |
Estradiol Valerate 4mg SR Table
|
|
1773 KB |
| 209 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) hard gelatin capsules (Phase III)
|
|
248 KB |
| 210 |
Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) Vaccine (Adsorbed)
|
|
308 KB |
| 211 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
318 KB |
| 212 |
Evenamide (NW-3509)2
|
|
269 KB |
| 213 |
AR-301
|
|
251 KB |
| 214 |
Evenamide2
|
|
379 KB |
| 215 |
Tirzepatide
|
|
256 KB |
| 216 |
Bedaquiline, Delamanid
|
|
360 KB |
| 217 |
Bedaquiline Tablets 100mg
|
|
255 KB |
| 218 |
Dienogest (Visanne®)
|
|
196 KB |
| 219 |
Tropifexor (LJN452) & licogliflozin
|
|
429 KB |
| 220 |
Typhoid Conjugate Vaccine (Monovalent)
|
|
289 KB |
| 221 |
Hydroxychloroquine Sulfate Tablet 200mg/300 mg
|
|
788 KB |
| 222 |
Goserelin 10.8mg Injection1
|
|
1460 KB |
| 223 |
Hydrocortisone Acetate Suppositories, 25 Mg
|
|
303 KB |
| 224 |
Ipatasertib
|
|
505 KB |
| 225 |
Inactivated Therapeutic Tuberculosis Vaccine.RUTI Vaccine
|
|
185 KB |
| 226 |
Inactivated Therapeutic Tuberculosis Vaccine
|
|
185 KB |
| 227 |
Fingolimod capsule
|
|
2608 KB |
| 228 |
Glimepiride IP + Voglibose IP + Metformin HCl IP (as ER) uncoated bilayered tablet (Phase IV)
|
|
242 KB |
| 229 |
Remogliflozin Etabonate + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film coated tablets (Phase III)
|
|
302 KB |
| 230 |
Silodosin + Solifenacin Succinate Ph. Eur. Capsule (Phase III)
|
|
337 KB |
| 231 |
Mirabegron + Solifenacin Succinate tablets (Phase III)
|
|
232 KB |
| 232 |
Ivabradin Tablet
|
|
2543 KB |
| 233 |
sacubitril/valsartan
|
|
251 KB |
| 234 |
Bilastine + Montelukast Sodium IP eq. to Montelukast uncoated tablet (Phase III)
|
|
297 KB |
| 235 |
Goserelin 10.8mg Injection
|
|
381 KB |
| 236 |
Selonsertib
|
|
1460 KB |
| 237 |
Brimonidine Tartrate 0.1% Ophthalmic Solution
|
|
325 KB |
| 238 |
PF-06741086
|
|
493 KB |
| 239 |
Evenamide(NW-3509/008/II/2019)
|
|
375 KB |
| 240 |
Capmatinib
|
|
249 KB |
| 241 |
Remogliflozin Etabonate Vildagliptin film coated tablet
|
|
1222 KB |
| 242 |
Hydrocortisone Acetate
|
|
358 KB |
| 243 |
Ripasudil HCl Hydrate eq. To Ripasudil Timolol Maleate IP Eq. To to Timolol eye drops
|
|
1008 KB |
| 244 |
Cephalexin extended release Clavulanate Potassium tablet
|
|
1016 KB |
| 245 |
Ceftazidime
|
|
321 KB |
| 246 |
Goserelin 3.6 mg Injection
|
|
495 KB |
| 247 |
Triamcinolone acetonide IP Lignocaine HCl IP Gel
|
|
712 KB |
| 248 |
Ceftazidime-Avibactam
|
|
489 KB |
| 249 |
GSK2831781
|
|
502 KB |
| 250 |
Lipidol
|
|
3028 KB |
| 251 |
Gepotidacin
|
|
256 KB |
| 252 |
Evenamide(NW-3509/006/III/2019)
|
|
509 KB |
| 253 |
Evenamide(nw-3509)
|
|
509 KB |
| 254 |
Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze Dried)
|
|
193 KB |
| 255 |
Prohance® (Gadoteridol 279.3 mg/mllnjection
|
|
2667 KB |
| 256 |
Dalbavancin
|
|
2754 KB |
| 257 |
opivacaine Hydrochloride USP eq. to anhydrous Ropivacaine hydrochloride Dextrose IP per ml injection
|
|
959 KB |
| 258 |
Azelnidipine Olmesartan Medoxomil IP tablets
|
|
1260 KB |
| 259 |
Benidipine HCl Chlorthalidone IPTelmisartan IP Film coated bilayered tablets
|
|
876 KB |
| 260 |
Rosuvastatin IP Teneligliptin Film coated tablet
|
|
1099 KB |
| 261 |
International Centre for Genetic Engineering and Biotechnology CampusBivalent (JAIVAC-2: PfMSPFu24 +PfF2/ Alhydrogel) P. falciparum malaria vaccine
|
|
167 KB |
| 262 |
SB3
|
|
249 KB |
| 263 |
Baricitinib eli lily
|
|
509 KB |
| 264 |
TRUNCATE – TB (tuberculosis)
|
|
3884 KB |
| 265 |
Lenvatinib Capsules 4 mg and 10 mg
|
|
330 KB |
| 266 |
Azilsartan KamedoxomilChlorthalidone IP tablet
|
|
654 KB |
| 267 |
Ticagrelor 120/180 mg SR Tablet
|
|
2652 KB |
| 268 |
AUR101
|
|
3310 KB |
| 269 |
Diptheria,Tetanus, Pertussis (Whole cell),Hepatitis B, Poliomyelitis (inactivated) and Haemophilus Influenzae Type b conjugate Vaccine (Adsorbed) [DTwPHepB-IPV-Hib vaccine (Adsorbed
|
|
207 KB |
| 270 |
Desidustat Tablet versus Epoetin alfa Injection
|
|
2558 KB |
| 271 |
AUR101
|
|
3310 KB |
| 272 |
Recombinant Hepatitis E Vaccine, Single Human Dose
|
|
266 KB |
| 273 |
PNB-001
|
|
267 KB |
| 274 |
Zileuton Ointment 1.25% and 5.0%
|
|
702 KB |
| 275 |
Inotuzumab
|
|
370 KB |
| 276 |
Avanafil tablets 100 mg & 200 mg
|
|
1223 KB |
| 277 |
Oral Baricitinib
|
|
503 KB |
| 278 |
LNP023(Rituximab)
|
|
260 KB |
| 279 |
Concizumab
|
|
327 KB |
| 280 |
Inactivated Hepatitis A Vaccine (Adsorbed) I.P.6nov
|
|
262 KB |
| 281 |
Concizumab Prophylaxis
|
|
508 KB |
| 282 |
LNP023
|
|
366 KB |
| 283 |
Iodixanol
|
|
2023 KB |
| 284 |
CT-P13
|
|
471 KB |
| 285 |
FEIBA
|
|
403 KB |
| 286 |
Etrasimod
|
|
485 KB |
| 287 |
Etrasimod( IQVIA)
|
|
502 KB |
| 288 |
Etrasimod( IQVIA RDS)
|
|
513 KB |
| 289 |
Brazikumab
|
|
491 KB |
| 290 |
GSK3196165
|
|
284 KB |
| 291 |
Ruxolitinib
|
|
310 KB |
| 292 |
Ruxolitinib
|
|
310 KB |
| 293 |
Spironolactone Topical Cream 5%
|
|
1495 KB |
| 294 |
Apremilast Film Coated 10/10/30mg Tablets
|
|
2755 KB |
| 295 |
Tenofovir Alafenamide, Emtricitabine and Bictegravir
|
|
2682 KB |
| 296 |
Sofosbuvir 400 mg Tablet
|
|
2627 KB |
| 297 |
Typhoid Vi conjugate VaccineRa
|
|
276 KB |
| 298 |
Cilnidipine IP Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets
|
|
609 KB |
| 299 |
Benidipine HCl IPTelmisartan IP Film coated tablets
|
|
641 KB |
| 300 |
Azelnidipine Telmisartan tablets
|
|
624 KB |
| 301 |
Typhoid Vi conjugate Vaccine30sep
|
|
185 KB |
| 302 |
Methylcobalamin Nasal spray 500 mcg
|
|
284 KB |
| 303 |
Certican / Zortress(everolimus EVR)
|
|
312 KB |
| 304 |
Tirzepatide
|
|
313 KB |
| 305 |
Tirzepatide1
|
|
313 KB |
| 306 |
QL1205 Versus Lucentis
|
|
304 KB |
| 307 |
HP-hMG and Menopur®
|
|
2143 KB |
| 308 |
Bupivacaine Hydrochloride IP eq. to anhydrous Bupivacaine Hydrochloride Fentanyl Citrate IP Eq. to Fentanyl injection
|
|
672 KB |
| 309 |
AT-10 (2-oxoclopidogrel bisulfate
|
|
2845 KB |
| 310 |
Inactivated Hepatitis A vaccine (Adsorbed) I.P.
|
|
187 KB |
| 311 |
Brazikumab
|
|
393 KB |
| 312 |
Rabies Vaccine, Human, I.P.
|
|
187 KB |
| 313 |
Ribociclib plus goserelin acetate
|
|
434 KB |
| 314 |
evenamide or placebo
|
|
273 KB |
| 315 |
semaglutide versus placebo
|
|
477 KB |
| 316 |
Meningococcal Conjugate Vaccine
|
|
510 KB |
| 317 |
Leuprolide acetate
|
|
2291 KB |
| 318 |
MYL-1701P and Eylea
|
|
299 KB |
| 319 |
Netarsudil Ophthalmic solution 0.02%
|
|
3055 KB |
| 320 |
ligelizumab (QGE031)
|
|
328 KB |
| 321 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 322 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 323 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 324 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial
|
|
705 KB |
| 325 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial)
|
|
697 KB |
| 326 |
Mirikizumab
|
|
625 KB |
| 327 |
Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial)
|
|
617 KB |
| 328 |
Tranexamic acid
|
|
1667 KB |
| 329 |
Menopausal Gonadotropin
|
|
2618 KB |
| 330 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (10-Valent)
|
|
259 KB |
| 331 |
k0706
|
|
592 KB |
| 332 |
baloxavir marboxil
|
|
492 KB |
| 333 |
Mirikizumab (UC)
|
|
625 KB |
| 334 |
Semaglutide (SOUL)
|
|
2366 KB |
| 335 |
traconazole
|
|
1373 KB |
| 336 |
Semaglutide
|
|
2366 KB |
| 337 |
Filgotinib (rheumatoid Arthritis)
|
|
519 KB |
| 338 |
Filgotinib
|
|
591 KB |
| 339 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB |
| 340 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB |
| 341 |
Capivasertib + Paclitaxel versus placebo
|
|
228 KB |
| 342 |
Tigilanol Tiglate
|
|
368 KB |
| 343 |
Oral Baricitinib
|
|
316 KB |
| 344 |
Baricitinib
|
|
500 KB |
| 345 |
Baricitinib
|
|
500 KB |
| 346 |
Evenamide
|
|
608 KB |
| 347 |
HD204 to Avastin®
|
|
513 KB |
| 348 |
Aceclofenac Topical ointment 1.5% w/wIII
|
|
2285 KB |
| 349 |
Beclomethasone
|
|
1765 KB |
| 350 |
Evenamide
|
|
608 KB |
| 351 |
Ulipristal acetate tablet 30mgIII
|
|
2555 KB |
| 352 |
IVIEW-1201
|
|
264 KB |
| 353 |
Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial)
|
|
643 KB |
| 354 |
Ribiciclib
|
|
289 KB |
| 355 |
INTP24 against Avastin® in
|
|
468 KB |
| 356 |
PMZ-1620
|
|
320 KB |
| 357 |
PMZ-1620
|
|
320 KB |
| 358 |
Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial
|
|
580 KB |
| 359 |
Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial)
|
|
357 KB |
| 360 |
Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial)
|
|
626 KB |
| 361 |
Lenalidomide
|
|
267 KB |
| 362 |
AS012
|
|
230 KB |
| 363 |
Osimertinib in Combination with Savolitinib
|
|
492 KB |
| 364 |
Crizanlizumab
|
|
303 KB |
| 365 |
Saroglitazar tablet 4mg II
|
|
2058 KB |
| 366 |
Biapenem 300 mg inj
|
|
368 KB |
| 367 |
Sulbactam-ETX2514
|
|
427 KB |
| 368 |
Rifapentine plus Isoniazid
|
|
259 KB |
| 369 |
Toujeo 300 Units/ml
|
|
486 KB |
| 370 |
Acotiamide ER tablet 300 tabletIII
|
|
2090 KB |
| 371 |
Recombinant Hepatitis E Vaccine
|
|
155 KB |
| 372 |
IQVIA
|
|
213 KB |
| 373 |
Ropivacaine Readyfusor 2mg/mlIII
|
|
2629 KB |
| 374 |
Oral Galactose
|
|
252 KB |
| 375 |
Vi-capsular Polysaccharide-CRM197 Conjugate Typhoid Vaccine
|
|
284 KB |
| 376 |
Semaglutide (NN9535-4352)
|
|
429 KB |
| 377 |
Semaglutide
|
|
429 KB |
| 378 |
Guselkumab
|
|
566 KB |
| 379 |
2Ó-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy
|
|
231 KB |
| 380 |
Pneumococcal polysaccharide conjugate vaccine (14-valent)
|
|
283 KB |
| 381 |
Typhoid Vi Conjugate Vaccine
|
|
280 KB |
| 382 |
Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet]
|
|
238 KB |
| 383 |
Xlucane versus Lucentis®
|
|
443 KB |
| 384 |
Neoadjuvant/adjuvantDurvalumab
|
|
427 KB |
| 385 |
Durvalumab
|
|
427 KB |
| 386 |
Rituximab Biosimilar (DRL_RI) with MabThera®
|
|
434 KB |
| 387 |
Phenobarbital Sodium Injection
|
|
191 KB |
| 388 |
Baricitinib
|
|
194 KB |
| 389 |
Tirzepatide
|
|
432 KB |
| 390 |
METREXASSIST™
|
|
194 KB |
| 391 |
FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV)
|
|
1031 KB |
| 392 |
C.O.M.B.A.T
|
|
222 KB |
| 393 |
esidustat vs Darbepoetin
|
|
295 KB |
| 394 |
Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel)
|
|
3105 KB |
| 395 |
Saroglitazar 2mg & 4mg Tablet
|
|
2767 KB |
| 396 |
Rivaroxaban tablets 2.5mg (Xarelto®)
|
|
2579 KB |
| 397 |
Oral Nafithromycin vs oral Moxifloxacin
|
|
417 KB |
| 398 |
Olaparib
|
|
250 KB |
| 399 |
TRC160334
|
|
295 KB |
| 400 |
Tacrolimus lipid tablet 3mg
|
|
2677 KB |
| 401 |
Typhoid Conjugate vaccineApril11
|
|
301 KB |
| 402 |
Fitusira
|
|
419 KB |
| 403 |
SB12 and Soliris
|
|
202 KB |
| 404 |
SAR341402 Mix 70/30 to NovoMix®3
|
|
337 KB |
| 405 |
Galcanezumab
|
|
327 KB |
| 406 |
Durvalumab
|
|
208 KB |
| 407 |
Lasmiditan
|
|
334 KB |
| 408 |
Norditropin®
|
|
427 KB |
| 409 |
Typhoid Conjugate vaccineTCV
|
|
299 KB |
| 410 |
Typhoid Conjugate vaccine
|
|
301 KB |
| 411 |
Pharmacokinetic and Pharmacodynamic
|
|
476 KB |
| 412 |
Pharmacokinetics of Murepavadin
|
|
248 KB |
| 413 |
Ipatasertib in Combination with Paclitaxel
|
|
194 KB |
| 414 |
IMU-131 HER2/neu
|
|
427 KB |
| 415 |
Inactivated Japanese Encephalitis Vaccine
|
|
451 KB |
| 416 |
Inactivated poliomyelitis vaccine 12March
|
|
149 KB |
| 417 |
10-valent Pneumococcal Conjugate Vaccine
|
|
322 KB |
| 418 |
Cetilistat
|
|
394 KB |
| 419 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
267 KB |
| 420 |
Octenidine Dihydrochloride
|
|
318 KB |
| 421 |
Bibrocathol 2% Eye ointment
|
|
303 KB |
| 422 |
Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil
|
|
2042 KB |
| 423 |
Norethisterone CR tablet 15mg
|
|
2068 KB |
| 424 |
Teneligliptin and Sitagliptin
|
|
247 KB |
| 425 |
secukinumab SUNSHINE
|
|
570 KB |
| 426 |
Secukinumab SUNRISE
|
|
570 KB |
| 427 |
iGlarLixi versus premixed
|
|
321 KB |
| 428 |
Edoxaban tosylate
|
|
220 KB |
| 429 |
Inactivated poliomyelitis vaccine
|
|
488 KB |
| 430 |
Durvalumab in combination
|
|
423 KB |
| 431 |
Liquid ROTAVAC 5CM (Live Attenuated Rotavirus Vaccine)
|
|
277 KB |
| 432 |
Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III)
|
|
1141 KB |
| 433 |
Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III)
|
|
1652 KB |
| 434 |
Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma
|
|
217 KB |
| 435 |
Tacrolimus lipid suspension 4mg/vial
|
|
1294 KB |
| 436 |
Oxaceprol tablet 600mg
|
|
1358 KB |
| 437 |
Baricitinib SLE
|
|
581 KB |
| 438 |
Ivermectin Lotion,0.5%
|
|
223 KB |
| 439 |
Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III)
|
|
1067 KB |
| 440 |
Ofatumumab toterability
|
|
195 KB |
| 441 |
Beclomethasone Dipropionate
|
|
581 KB |
| 442 |
Durvalumab Monotherapy
|
|
355 KB |
| 443 |
Phase 3 Relamorelin
|
|
413 KB |
| 444 |
15-Valent Pneumococcal Conjugate Vaccine (PCV15)
|
|
322 KB |
| 445 |
JHL1101
|
|
498 KB |
| 446 |
Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III)
|
|
1695 KB |
| 447 |
Rotavirus Vaccine
|
|
321 KB |
| 448 |
Measles and Rubella Vaccine (Live)
|
|
320 KB |
| 449 |
efficacy ART-123
|
|
439 KB |
| 450 |
Relamorelin gastroparesis
|
|
238 KB |
| 451 |
Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III)
|
|
1117 KB |
| 452 |
SHP640
|
|
196 KB |
| 453 |
Teriflunomide tab 14 mg
|
|
428 KB |
| 454 |
HRF-4467
|
|
228 KB |
| 455 |
Durvalumab plus Olaparib
|
|
1481 KB |
| 456 |
PNB028
|
|
266 KB |
| 457 |
Prednisone delayed Release Tablet 5 mg
|
|
2670 KB |
| 458 |
Itraconazole
|
|
1378 KB |
| 459 |
Durvalumab as Consolidation therapy
|
|
1497 KB |
| 460 |
Enbrel®’ (Etanercept
|
|
1379 KB |
| 461 |
Dexamethasone Sodium Phosphate
|
|
1600 KB |
| 462 |
Relamorelin
|
|
1680 KB |
| 463 |
Single dose Del Nido vs multi dose StThomas II Cardioplegia
|
|
235 KB |
| 464 |
CPL-2009-0031 tablet 140 mg
|
|
277 KB |
| 465 |
Azacitidine
|
|
239 KB |
| 466 |
PMZ-2010
|
|
283 KB |
| 467 |
CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd
|
|
222 KB |
| 468 |
Durvalumab
|
|
1405 KB |
| 469 |
LNP3794 in apatients
|
|
1411 KB |
| 470 |
Pembrolizumab
|
|
1412 KB |
| 471 |
Crizanlizumab
|
|
1410 KB |
| 472 |
Dupilumab
|
|
1781 KB |
| 473 |
Ifetroban
|
|
1415 KB |
| 474 |
TX05
|
|
1595 KB |
| 475 |
Herceptin® or TX05
|
|
1438 KB |
| 476 |
CT-P16
|
|
1586 KB |
| 477 |
Ivabradine Tablets
|
|
2291 KB |
| 478 |
Aztreonam-Avibactam (Atm-Avi)
|
|
1491 KB |
| 479 |
Cefepime-Tazobactam vs. Meropenem
|
|
1484 KB |
| 480 |
ligelizumab (QGE031)
|
|
1696 KB |
| 481 |
ZS (sodium zirconium cyclosilicate
|
|
1636 KB |
| 482 |
Selinexor (KPT-330
|
|
1592 KB |
| 483 |
tropifexor (LJN452) and cenicriviroc (CVC)
|
|
1460 KB |
| 484 |
Semaglutide
|
|
1601KB |
| 485 |
Ligelizumab (QGE031)
|
|
1614 KB |
| 486 |
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5%
|
|
1449 KB |
| 487 |
Coversin
|
|
1489 KB |
| 488 |
NexoBrid
|
|
1513 KB |
| 489 |
PXL01
|
|
1568 KB |
| 490 |
Epinephrine plus Vasopressin
|
|
226KB |
| 491 |
Azelnidipine tab 8 mg / 16 mg
|
|
287 KB |
| 492 |
Azacitidine 100 mg
|
|
280 KB |
| 493 |
Saroglitazar Magnesium
|
|
17176 KN |
| 494 |
VELPANAT
|
|
197 KB |
| 495 |
Azelnidipine
|
|
371 KB |
| 496 |
FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets.
|
|
17177 KB |
| 497 |
Doxycycline
|
|
225 KB |
| 498 |
Pregabalin
|
|
212 KB |
| 499 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
218 KB |
| 500 |
Tulobuterol Transdermal
|
|
239 KB |
| 501 |
Enterogermina
|
|
179 KB |
| 502 |
Desidustat ZYAN1
|
|
236 KB |
| 503 |
PMZ-1620
|
|
259 KB |
| 504 |
Nexagon® (NEXAGON)
|
|
1530 KB |
| 505 |
Tapentadol nasal spray 225mg/ml
|
|
966 KB |
| 506 |
Semaglutide
|
|
1637 KB |
| 507 |
Mirikizumab
|
|
1850 KB |
| 508 |
Edoxaban
|
|
1794 KB |
| 509 |
EG12014
|
|
1782 KB |
| 510 |
Mirikizumab
|
|
1786 KB |
| 511 |
LCZ696
|
|
1762 KB |
| 512 |
Ticagrelor
|
|
1672 KB |
| 513 |
5-aminolevulinic acid hydrochloride
|
|
1845 KB |
| 514 |
Brolucizumab
|
|
1822 KB |
| 515 |
Aztreonam-Avibactam (ATM-AVI Pfizer
|
|
2029 KB |
| 516 |
Granexin Gel
|
|
545 KB |
| 517 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB |
| 518 |
KAF156
|
|
1902 KB |
| 519 |
Efpeglenatide
|
|
444 KB |
| 520 |
Osilodrostat (LCI699
|
|
1794 KB |
| 521 |
Esmolol Hydrochloride 14.00% w/w topical gel
|
|
1298 KB |
| 522 |
FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets
|
|
1246 KB |
| 523 |
Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units
|
|
1737 KB |
| 524 |
Dalfampridine
|
|
124 KB |
| 525 |
Osimertinib
|
|
1773 KB |
| 526 |
Apremilast Tablets 10/20/30mg Phase IV .
|
|
1708 KB |
| 527 |
FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets
|
|
1300 KB |
| 528 |
FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets
|
|
1316 KB |
| 529 |
EG12014
|
|
1782 KB |
| 530 |
Mirikizumab
|
|
1850 KB |
| 531 |
Edoxaban
|
|
1794 KB |
| 532 |
LCZ696
|
|
1762 KB |
| 533 |
Osilodrostat (LCI699
|
|
1794 KB |
| 534 |
Mirikizumab
|
|
1786 KB |
| 535 |
Pilot study on Paracetamol Injection for IM route Pilot study
|
|
1593 KB |
| 536 |
Paracetamol Injection 500mg/2ml for IM route Phase III
|
|
1960 KB |
| 537 |
Bilastine 20 mg
|
|
312 KB |
| 538 |
Magnesium sulfate
|
|
116 KB |
| 539 |
Dolutegravir (Phase IV)
|
|
78.6 KB |
| 540 |
TRC041266
|
|
195 KB |
| 541 |
Scrub Typhus INTREST
|
|
1820 KB |
| 542 |
KAF156
|
|
1902 KB |
| 543 |
Ticagrelor
|
|
1672 KB |
| 544 |
5-aminolevulinic acid hydrochloride
|
|
1854 KB |
| 545 |
Brolucizumab
|
|
1822 KB |
| 546 |
Aztreonam-Avibactam (ATM-AVI
|
|
2029 KB |
| 547 |
Granexin Gel
|
|
545 KB |
| 548 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB |
| 549 |
Kyprolis (Carfilzomib)
|
|
184 KB |
| 550 |
Sodium Copper Chlorophyllin
|
|
155 KB |
| 551 |
Tagrisso (Osimertinib)
|
|
137 KB |
| 552 |
Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III).
|
|
1,118 KB |
| 553 |
Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III).
|
|
1,163 KB |
| 554 |
Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III)
|
|
1,008 KB |
| 555 |
Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III).
|
|
949 KB |
| 556 |
Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III)
|
|
1,027 KB |
| 557 |
Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III).
|
|
1,195 KB |
| 558 |
Semaglutide 2.4 mg
|
|
1,708 KB |
| 559 |
Durvalumab
|
|
260 KB |
| 560 |
Efpeglenatide
|
|
444 KB |
| 561 |
Sotagliflozin
|
|
1,910 KB |
| 562 |
Filgotinib
|
|
1,786 KB |
| 563 |
emaglutide 2.4 mg CT/18/000019
|
|
1,708 KB |
| 564 |
Semaglutide 2.4 mg
|
|
1,722 KB |
| 565 |
Cinacalcet Hydrochloride
|
|
1,710 KB |
| 566 |
Delamanid
|
|
82 KB |
| 567 |
Desidustat
|
|
106 KB |
| 568 |
Azelnidipine tab 16 mg
|
|
130 KB |
| 569 |
Enzalutamide
|
|
98.6 KB |
| 570 |
Calcipotriol/AKVANO 50 µg/g cutaneous solution
|
|
1,737,836 KB |
| 571 |
Efpeglenatide
|
|
444 KB |
| 572 |
Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis "
|
|
97KB |
| 573 |
Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX
|
|
143KB |
| 574 |
Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB"
|
|
76KB |
| 575 |
Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension "
|
|
128KB |
| 576 |
Ivermectin topical lotion 0.5% w/w
|
|
1,858,593 KB |
| 577 |
Darunavir Tablet 800mg
|
|
143KB |
| 578 |
Erdafitinib
|
|
1803 KB |
| 579 |
Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy"
|
|
105KB |
| 580 |
Canakinumab
|
|
1877 KB |
| 581 |
Paliperidone Palmitate
|
|
1757 KB |
| 582 |
Rigosertib
|
|
1688 KB |
| 583 |
Fitusiran
|
|
1875 KB |
| 584 |
Atezolizumab
|
|
1769 KB |
| 585 |
YLB113
|
|
299KB |
| 586 |
AMG 334
|
|
392KB |
| 587 |
Baricitinib
|
|
300KB |
| 588 |
Torsemide Extended Release
|
|
568KB |
| 589 |
QAW039
|
|
570KB |
| 590 |
Baricitinib
|
|
300KB |
| 591 |
NexoBrid
|
|
302KB |
| 592 |
Emicizumab
|
|
371KB |
| 593 |
MB02 (Bevacizumab Biosimilar Drug)
|
|
573KB |
| 594 |
Rilpivirine
|
|
577KB |
| 595 |
Exenatide
|
|
373KB |
| 596 |
SCY 078
|
|
242KB |
| 597 |
Pimodivir
|
|
1718 KB |
| 598 |
Fitusiran
|
|
1758 KB |
| 599 |
CLS-TA
|
|
1814 KB |
| 600 |
Pimodivir15
|
|
1640 KB |
| 601 |
ASN100
|
|
1753 KB |
| 602 |
MEDI-551
|
|
1763 KB |
| 603 |
Regorafenib
|
|
140KB |
| 604 |
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg
|
|
1750 KB |
| 605 |
QVM149
|
|
1804 KB |
| 606 |
Lenvatinib
|
|
143KB |
| 607 |
Sofosbuvir / Velpatasvir FDC
|
|
100KB |
| 608 |
Februric (Febuxostat)
|
|
103KB |
| 609 |
Pirfenidone
|
|
100KB |
| 610 |
Anagliptin
|
|
162KB |
| 611 |
Verapamil ER
|
|
193KB |
| 612 |
Heptral
|
|
105KB |
| 613 |
Spironolactone cream 5%
|
|
926KB |
| 614 |
Heptral
|
|
105kb |
| 615 |
BIO-11006
|
|
565 KB |
| 616 |
LUBT010
|
|
371 KB |
| 617 |
Ataluren
|
|
269 KB |
| 618 |
Nintedanib Systemic Sclerosis
|
|
404 KB |
| 619 |
ABP 798
|
|
340 KB |
| 620 |
Selinexor (KPT-330)
|
|
445 KB |
| 621 |
ribociclib with endocrine
|
|
423 KB |
| 622 |
Dapagliflozin 5 and 10 mg
|
|
447 KB |
| 623 |
Dinutuximab and Irinotecan
|
|
456 KB |
| 624 |
SB11
|
|
282 KB |
| 625 |
Atezolizumab compared with chemotherapy
|
|
109 KB |
| 626 |
Lorlatinib (PF-06463922)
|
|
470 KB |
| 627 |
Canagliflozin in Children
|
|
439 KB |
| 628 |
Povidone-Iodine Nail Solution
|
|
103 KB |
| 629 |
Denosumab
|
|
320 KB |
| 630 |
CLS-TA Sapphire
|
|
100 KB |
| 631 |
Selinexor
|
|
448 KB |
| 632 |
Bempedoic Acid (ETC-1002)
|
|
582 KB |
| 633 |
LJN452
|
|
367 KB |
| 634 |
Atezolizumab(ANTI-PD-L1Antibody)
|
|
907 KB |
| 635 |
Ticagrlor
|
|
1115 KB |
| 636 |
Deferasirox Formulation(Granules)
|
|
842 KB |
| 637 |
Ruxolitinib
|
|
849 KB |
| 638 |
LCZ696 on NT Pro BNP
|
|
1117 KB |
| 639 |
Alpelisib
|
|
861 KB |
| 640 |
Ixekizumab
|
|
1165 KB |
| 641 |
QAW039 sept
|
|
1132 KB |
| 642 |
PEGylated factor
|
|
1154 KB |
| 643 |
Abemaciclib
|
|
1210 KB |
| 644 |
Apixaban
|
|
1104 KB |
| 645 |
RSV
|
|
868 KB |
| 646 |
Empagliflozin 10mg
|
|
1138 KB |
| 647 |
Empagliflozin
|
|
1228 KB |
| 648 |
LY900014 (Insulin Lispro)
|
|
1115 KB |
| 649 |
ANF-Rho
|
|
1125 KB |
| 650 |
SPI-2012
|
|
876 KB |
| 651 |
SAIT101 vs Rituximab
|
|
1353 KB |
| 652 |
Dapagliflozin PC D1699C00001
|
|
1064 KB |
| 653 |
ovidone -Iodine
|
|
1133 KB |
| 654 |
MOD-4023
|
|
1274 KB |
| 655 |
Safety Study of Atezolizumab
|
|
814 KB |
| 656 |
Eltrombopag
|
|
867 KB |
| 657 |
LNP1892
|
|
1018 KB |
| 658 |
Dulaglutide
|
|
985 KB |
| 659 |
Ribociclib
|
|
846 KB |
| 660 |
Canagliflozin
|
|
1121 KB |
| 661 |
QMF149 150-80 microgram
|
|
1039 KB |
| 662 |
Secukinumab
|
|
888 KB |
| 663 |
sFilgotinib
|
|
1171 KB |
| 664 |
Filgotinib Crohn
|
|
1203 KB |
| 665 |
Filgotinib combined phase
|
|
1008 KB |
| 666 |
Filgotinib Rheumatoid
|
|
842 KB |
| 667 |
LNP3794
|
|
819 KB |
| 668 |
Filgotinib Administered
|
|
196 KB |
| 669 |
LY900014
|
|
1048 KB |
| 670 |
Tenofovir Alafenamide
|
|
1111 KB |
| 671 |
Filgotinib
|
|
198 KB |
| 672 |
Dapagliflozin
|
|
1168 KB |
| 673 |
CLS-TA
|
|
59 KB |
| 674 |
Selonsertib
|
|
1320 KB |
| 675 |
Filgotinib safety
|
|
1238 KB |
| 676 |
Masitinib vs Placebo
|
|
807 KB |
| 677 |
Pemafibrate
|
|
1356 KB |
| 678 |
Ribociclib LEE011
|
|
831 KB |
| 679 |
Selonsertib NASH
|
|
1326 KB |
| 680 |
Bedaquiline
|
|
152 KB |
| 681 |
Daprodustat
|
|
183 KB |
| 682 |
aprodustat
|
|
227 KB |
| 683 |
Oral Semaglutide versus
|
|
192 KB |
| 684 |
LCZ696
|
|
145 KB |
| 685 |
SAIT101
|
|
148 KB |
| 686 |
Alphanate®
|
|
139 KB |
| 687 |
TK-112690
|
|
172 KB |
| 688 |
Ofatumumab
|
|
188 KB |
| 689 |
Etrolizumab PhaseII/III
|
|
204 KB |
| 690 |
Ofatumumab safety
|
|
186 KB |
| 691 |
Clindamycin phosphate
|
|
178 KB |
| 692 |
Etrolizumab
|
|
207 KB |
| 693 |
Pradaxa Capsules
|
|
155 KB |
| 694 |
DE-117
|
|
200 KB |
| 695 |
Lixisenatide
|
|
204 KB |
| 696 |
QVA149
|
|
294 KB |
| 697 |
Aclidinium
|
|
229 KB |
| 698 |
Nintedanib oral
|
|
197 KB |
| 699 |
Sarizotan
|
|
142 KB |
| 700 |
CBT124
|
|
222 KB |
| 701 |
Palbociclib
|
|
178 KB |
| 702 |
LY2835219
|
|
295 KB |
| 703 |
Avelumab
|
|
150 KB |
| 704 |
FIASP
|
|
143 KB |
| 705 |
Insulin Degludec
|
|
156 KB |
| 706 |
Guidance Document for Export NOC
|
|
137kb |
| 707 |
Guidance for global access of OCTAMS
|
|
1,138kb |
| 708 |
Manual of OCTAMS
|
|
4,561kb |
| 709 |
Report Book
|
|
5,165kb |
| 710 |
Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO
|
|
4,818kb |
| 711 |
Sofosbuvir Velpatasvir
|
|
158 KB |
| 712 |
Cardiovascular safety of Oral Semaglutide
|
|
216 KB |
| 713 |
Budesonide
|
|
150 KB |
| 714 |
MYL-14020
|
|
280 KB |
| 715 |
Vedolizumab IV
|
|
152 KB |
| 716 |
Dexamethasone sodium
|
|
141 KB |
| 717 |
Pegylated Interferon @-2a
|
|
143 KB |
| 718 |
BCD-055
|
|
148 KB |
| 719 |
Liraglutide
|
|
136 KB |
| 720 |
NC0195-0092
|
|
130 KB |
| 721 |
QAW039
|
|
128 KB |
| 722 |
Oral Semaglutide
|
|
133 KB |
| 723 |
GS-5745
|
|
138 KB |
| 724 |
RFB002
|
|
135 KB |
| 725 |
Trimcinolone Acetonide
|
|
173 KB |
| 726 |
Semaglutide IGlar SGT2i
|
|
160 KB |
| 727 |
Rivaroxaban
|
|
148 KB |
| 728 |
MEDI4736 aug
|
|
211 KB |
| 729 |
Ceritinib
|
|
144 KB |
| 730 |
MEDI4736
|
|
189 KB |
| 731 |
INC280
|
|
2112 KB |
| 732 |
Ticagrelor
|
|
158 KB |
| 733 |
Indacaterol
|
|
277 KB |
| 734 |
QMF149
|
|
225 KB |
| 735 |
BIASP-30
|
|
198 KB |
| 736 |
Insulin Aspart
|
|
195 KB |
| 737 |
NW-3509A
|
|
153 KB |
| 738 |
Insulin degludec may
|
|
216 KB |
| 739 |
Lopinavir/Ritonavir
|
|
144 KB |
| 740 |
MDR-TB Drugs
|
|
151 KB |
| 741 |
Sofosbuvir
|
|
143 KB |
| 742 |
B1695502
|
|
225 KB |
| 743 |
RLX030
|
|
190 KB |
| 744 |
Clindamycin
|
|
189 KB |
| 745 |
Semaglutide 2016
|
|
256 KB |
| 746 |
Masitinib
|
|
178 KB |
| 747 |
Carbetocin RTS
|
|
1542 KB |
| 748 |
YLB113
|
|
184 KB |
| 749 |
Insulin degludec
|
|
245 KB |
| 750 |
BYL719
|
|
189 KB |
| 751 |
LEE011
|
|
183 KB |
| 752 |
Nintedanib
|
|
204 KB |
| 753 |
Pregabali
|
|
182 KB |
| 754 |
Bevacizumab
|
|
181 KB |
| 755 |
Pregabalin
|
|
182 KB |
| 756 |
Recruitment Rule of Drugs Inspector in CDSCO
|
|
2,512kb |
| 757 |
Alirocumab
|
|
191 KB |
| 758 |
CT P10
|
|
186 KB |
| 759 |
QGE031 CQGE031B2201
|
|
166 KB |
| 760 |
QGE031 S.c
|
|
191 KB |
| 761 |
FG-3019s
|
|
190 KB |
| 762 |
Roxadustat
|
|
187 KB |
| 763 |
Roxadustat Anemia
|
|
190 KB |
| 764 |
Subcutaneous Secukinumab
|
|
221 KB |
| 765 |
GENA-05
|
|
160 KB |
| 766 |
Dydrogesterone
|
|
178 KB |
| 767 |
Pregabalin as adjunctive
|
|
171 KB |
| 768 |
Linaclotide
|
|
225 KB |
| 769 |
LCZ696 NYHA
|
|
204 KB |
| 770 |
LCZ696 Paradigm
|
|
235 KB |
| 771 |
Moroctocog alfa
|
|
166 KB |
| 772 |
RanibizumAB
|
|
173 KB |
| 773 |
Canagloflozin
|
|
209 KB |
| 774 |
Steroids in Iga
|
|
181 KB |
| 775 |
Insulin Aspart BIAsp
|
|
201 KB |
| 776 |
Salmeterol
|
|
193 KB |
| 777 |
Masitinib Lymphoma
|
|
189 KB |
| 778 |
LEE011 NSAI
|
|
182 KB |
| 779 |
Checklist for Test License Appli8cations Effective From 15 June 2011
|
|
143kb |
| 780 |
Guidance Document on Grant of Licenses in Form 11(Test License)
|
|
618kb |
| 781 |
Amended Checklist for test License Applications Effective From 15 June2011
|
|
69kb |
| 782 |
DE-109
|
|
180 KB |
| 783 |
Octafibrin
|
|
170 KB |
| 784 |
ACTG 5288
|
|
170 KB |
| 785 |
Dabigatran etexilate dual
|
|
239 KB |
| 786 |
Clindamycin 1%
|
|
215 KB |
| 787 |
Bococizumab
|
|
369 KB |
| 788 |
LEE011 with Lerozole
|
|
184 KB |
| 789 |
Bococizumab PF-04950615)
|
|
368 KB |
| 790 |
Masitinib
|
|
210 KB |
| 791 |
Masitinib Folfiri
|
|
209 KB |
| 792 |
Dabigatran Etexilate
|
|
255 KB |
| 793 |
Rituximab
|
|
190 KB |
| 794 |
Chemotherapy
|
|
178 KB |
| 795 |
Dabigatran
|
|
197 KB |
| 796 |
Fibrinogen
|
|
182 KB |
| 797 |
2 PARALLEL Masitinib
|
|
213 KB |
| 798 |
Chemoradiation
|
|
162 KB |
| 799 |
Ticagelor
|
|
189 KB |
| 800 |
QGE031
|
|
183 KB |
| 801 |
Isoniazid
|
|
172 KB |
| 802 |
Tiotropium
|
|
265 KB |
| 803 |
Nifedipine Daga
|
|
165 KB |
| 804 |
Labetalol
|
|
162 KB |
| 805 |
DS-5565
|
|
178 KB |
| 806 |
Nifedipine Daga
|
|
165 KB |
| 807 |
LY2963019
|
|
200 KB |
| 808 |
Insulin Detemir
|
|
181 KB |
| 809 |
NNC0195-0092
|
|
188 KB |
| 810 |
Pasireotidestudy
|
|
171 KB |
| 811 |
Mifepristone and Misoprotol
|
|
163 KB |
| 812 |
Pasireotide
|
|
173 KB |
| 813 |
LCI699
|
|
173 KB |
| 814 |
Mifepristone
|
|
160 KB |
| 815 |
Policy Initiatives Planned for 2015
|
|
85kb |
| 816 |
LY2605541
|
|
200 KB |
| 817 |
Antidepressant
|
|
149 KB |
| 818 |
Octafibrin GCT/64/14
|
|
197 KB |
| 819 |
Semaglutide 2014
|
|
198 KB |
| 820 |
Alglucosidase Alfa
|
|
164 KB |
| 821 |
Dabigatran BI 655075
|
|
223 KB |
| 822 |
Ranibizumab VEGF
|
|
180 KB |
| 823 |
Ranibizumab Brilliance
|
|
191 KB |
| 824 |
Ranibizumab CRVO
|
|
180 KB |
| 825 |
Trastuzumab
|
|
216 KB |
| 826 |
Rituximab RTXM83
|
|
185 KB |
| 827 |
Afatinib BiBW 2992
|
|
189 KB |
| 828 |
Afatinib for Patients
|
|
172 KB |
| 829 |
Alglucosidase
|
|
171 KB |
| 830 |
Herpes Zoster
|
|
169 KB |
| 831 |
Pregabalin Adjunctive
|
|
188 KB |
| 832 |
Paclitaxel
|
|
178 KB |
| 833 |
Eravacycline
|
|
197 KB |
| 834 |
UT-15C
|
|
176 KB |
| 835 |
UT-15C Phase III
|
|
189 KB |
| 836 |
Dapagliflozin 10mg
|
|
201 KB |
| 837 |
Bevacizumab AVASTIN
|
|
178 KB |
| 838 |
Pertuzumab
|
|
180 KB |
| 839 |
LDK378
|
|
219 KB |
| 840 |
Pasireotide LAR
|
|
163 KB |
| 841 |
Ifetroban Injection
|
|
192 KB |
| 842 |
FactorVIII
|
|
122 KB |
| 843 |
Baricitinib in Patients
|
|
222 KB |
| 844 |
Adalimumab
|
|
179 KB |
| 845 |
Cyclosporine
|
|
190 KB |
| 846 |
Fluocinolone acetonide intravitreal
|
|
174 KB |
| 847 |
Ranibizumab 0.5 mg
|
|
188 KB |
| 848 |
Everolimus with reduced calcineurin
|
|
256 KB |
| 849 |
Fosaprepitant
|
|
191 KB |
| 850 |
Sitagliptin
|
|
213 KB |
| 851 |
Liraglutide Sitagliptin
|
|
181 KB |
| 852 |
Masitinib
|
|
198 KB |
| 853 |
NOVA22007
|
|
191 KB |
| 854 |
QAW039 on FEV1
|
|
184 KB |
| 855 |
Clindamycin benzoyal peroxide
|
|
265 KB |
| 856 |
BCD-020
|
|
223 KB |
| 857 |
Pasireotide S.C
|
|
173 KB |
| 858 |
Ciprodex
|
|
212 KB |
| 859 |
Enbrel
|
|
194 KB |
| 860 |
Ceftazidime CAZ AVI
|
|
200 KB |
| 861 |
Exenatide
|
|
174 KB |
| 862 |
Daclizumab
|
|
186 KB |
| 863 |
Remicade
|
|
215 KB |
| 864 |
Buparlisib
|
|
182 KB |
| 865 |
BCD-021
|
|
214 KB |
| 866 |
Liraglutide versus sulphonylurea
|
|
211 KB |
| 867 |
Insulin Degludec versus insulin glargine
|
|
277 KB |
| 868 |
BCD-022
|
|
217 KB |
| 869 |
tolerability of Secukinumab
|
|
176 KB |
| 870 |
Everolimus RADOO1
|
|
192 KB |
| 871 |
Everolimus alone
|
|
183 KB |
| 872 |
Transfer Policy
|
|
421kb |
| 873 |
SAR236553
|
|
681 KB |
| 874 |
Afatinib
|
|
225 KB |
| 875 |
subcutaneous Secukinumab
|
|
166 KB |
| 876 |
Sofosbuvir plus ribavirin
|
|
291 KB |
| 877 |
Ceftazidime
|
|
283 KB |
| 878 |
Everolimus
|
|
243 KB |
| 879 |
Fluocinolone
|
|
292 KB |
| 880 |
FLU D-QIV
|
|
278 KB |
| 881 |
FIAsP Insulin
|
|
280 KB |
| 882 |
FIAsP 2014
|
|
279 KB |
| 883 |
Tenofovir Disoproxil
|
|
303 KB |
| 884 |
Tenofovir Alafenamide TAF
|
|
314 KB |
| 885 |
olasertib
|
|
289 KB |
| 886 |
Baricitinib LY3009104
|
|
348 KB |
| 887 |
Diclofenac Gel
|
|
370 KB |
| 888 |
Baricitinib
|
|
357 KB |
| 889 |
TechnologyMG145
|
|
1410 KB |
| 890 |
BEZ235
|
|
846 KB |
| 891 |
Producttrastuzumab
|
|
926 KB |
| 892 |
LAF237
|
|
293 KB |
| 893 |
Liraglutide sc Injection
|
|
306 KB |
| 894 |
Fesoterodine
|
|
305 KB |
| 895 |
Human rh FV III
|
|
301 KB |
| 896 |
Octefibrin
|
|
290 KB |
| 897 |
CP-690,550
|
|
296 KB |
| 898 |
Lixisenatid Subcutaneous
|
|
382 KB |
| 899 |
Tenofovir
|
|
342 KB |
| 900 |
ART-123
|
|
303 KB |
| 901 |
Quotation of rate contract for supply of Photostat Paper (JK Brand) Last date (27 Jul 2012 )
|
|
129kb |
| 902 |
Re-tendering for Housekeeping and General cleanliness in the CDSCO(HQ), FDA Bhawan, Kotla Road, New Delhi Last Date ( 27 Jul 2012 )
|
|
903kb |
| 903 |
Extension of Date of Notice Inviting Tender (NIT) Last Date( 27 Jul 2012 )
|
|
370kb |
| 904 |
Annual Rate Contract for Hiring taxies 1 Last Date( 27 Jul 2012 )
|
|
132kb |
| 905 |
Annual Rate Contract for Hiring taxies 2 Last Date ( 27 Jul 2012 )
|
|
1,775kb |
| 906 |
Annual Rate Contract for Hiring taxies 3 Last Date( 27 Jul 2012 )
|
|
162kb |
Downloads/Documents & Publications